|
JPS60136511A
(ja)
|
1983-12-26 |
1985-07-20 |
Eisai Co Ltd |
高尿酸血症治療剤
|
|
WO1987001938A1
(en)
|
1985-09-27 |
1987-04-09 |
The Regents Of The University Of California |
Liposome transdermal drug delivery system
|
|
JPS6295134A
(ja)
|
1985-10-21 |
1987-05-01 |
Nippon Saafuakutanto Kogyo Kk |
リポソ−ムの製造法
|
|
US5015483A
(en)
|
1989-02-09 |
1991-05-14 |
Nabisco Brands, Inc. |
Liposome composition for the stabilization of oxidizable substances
|
|
US5498607A
(en)
|
1990-07-30 |
1996-03-12 |
University Of Miami |
Treatment for hypercholesterolemia
|
|
US6165500A
(en)
|
1990-08-24 |
2000-12-26 |
Idea Ag |
Preparation for the application of agents in mini-droplets
|
|
JP3765579B2
(ja)
|
1990-08-24 |
2006-04-12 |
イーデーエーアー アーゲー |
作用物質投与用超微小滴状調剤
|
|
US5498420A
(en)
|
1991-04-12 |
1996-03-12 |
Merz & Co. Gmbh & Co. |
Stable small particle liposome preparations, their production and use in topical cosmetic, and pharmaceutical compositions
|
|
EP0648114B1
(de)
|
1992-07-08 |
1997-09-17 |
DIANORM G. Maierhofer GmbH |
Liposomen, verfahren zu ihrer herstellung und ihre verwendung zur herstellung eines arzneimittels
|
|
FR2714382B1
(fr)
|
1993-12-27 |
1996-02-02 |
Roussel Uclaf |
Phospholipides vecteur de molécule active, leur préparation et leur utilisation dans des compositions cosmétiques ou dermatologiques.
|
|
DE4447287C1
(de)
|
1994-12-30 |
1996-11-07 |
Cevc Gregor |
Präparat zum Wirkstofftransport durch Barrieren
|
|
US5902604A
(en)
|
1995-06-06 |
1999-05-11 |
Board Of Regents, The University Of Texas System |
Submicron liposome suspensions obtained from preliposome lyophilizates
|
|
FR2767691B1
(fr)
|
1997-08-27 |
2000-02-18 |
Oreal |
Utilisation d'une dispersion a base de vehicules lipidiques comme composition anti-inflammatoire
|
|
ATE210438T1
(de)
*
|
1997-11-19 |
2001-12-15 |
Schering Ag |
Zusammensetzung mit azelainsäure
|
|
US6165997A
(en)
|
1997-11-20 |
2000-12-26 |
Statens Serum Institut |
Phospholipids having antimicrobial activity with or without the presence of antimicrobials
|
|
MXPA01002149A
(es)
|
1998-09-01 |
2003-03-27 |
Idea Ag |
Transporte electricamente controlado de penetrantes cargados a traves de barreras.
|
|
JP2002533379A
(ja)
|
1998-12-23 |
2002-10-08 |
イデア アクチェンゲゼルシャフト |
生体内における局所的に非侵襲性である用途のための改善された製剤
|
|
ATE216875T1
(de)
|
1999-01-27 |
2002-05-15 |
Idea Ag |
Nichtinvasive impfung durch die haut
|
|
US6294192B1
(en)
|
1999-02-26 |
2001-09-25 |
Lipocine, Inc. |
Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
|
|
WO2001001962A1
(en)
|
1999-07-05 |
2001-01-11 |
Idea Ag. |
A method for the improvement of transport across adaptable semi-permeable barriers
|
|
US6248728B1
(en)
|
2000-03-10 |
2001-06-19 |
Kansas State University Research Foundation |
Phosphatidylcholine compositions and methods for lowering intestinal absorption and plasma levels of cholesterol
|
|
US6191121B1
(en)
*
|
2000-04-06 |
2001-02-20 |
Nicholas V. Perricone |
Treatment of skin damage using polyenylphosphatidylcholine
|
|
ES2270991T3
(es)
|
2000-04-12 |
2007-04-16 |
Liplasome Pharma A/S |
Sistemas basados en lipidos para el direccionado de agentes de diagnostico.
|
|
TWI281407B
(en)
|
2000-09-18 |
2007-05-21 |
Vasogen Ireland Ltd |
Apoptosis-mimicking synthetic entities and use thereof in medical treatment
|
|
US20030064948A1
(en)
|
2001-02-08 |
2003-04-03 |
Alfred Fahr |
Invasomes for therapy of disorders, their preparation and use
|
|
KR20040033286A
(ko)
|
2001-05-31 |
2004-04-21 |
파마시아 코포레이션 |
선택적인 사이클로옥시게나제-2 억제제 및 1가 알콜을포함하는 피부-침투성 조성물
|
|
CA2451245A1
(en)
|
2001-06-25 |
2003-01-03 |
Depuy International Limited |
Liposomal encapsulation of glycosaminoglycans for the treatment of arthritic joints
|
|
CA2368656A1
(en)
|
2002-01-21 |
2003-07-21 |
Vasogen Ireland Limited |
Receptor-ligand pairing for anti-inflammatory response
|
|
AU2003233396B2
(en)
|
2002-03-13 |
2007-05-24 |
Thomas Skold |
Water-based delivery systems
|
|
US20040009180A1
(en)
|
2002-07-11 |
2004-01-15 |
Allergan, Inc. |
Transdermal botulinum toxin compositions
|
|
US20040105881A1
(en)
|
2002-10-11 |
2004-06-03 |
Gregor Cevc |
Aggregates with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin
|
|
AU2003273977B2
(en)
|
2002-10-11 |
2007-07-12 |
Idea Ag |
Aggregate with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin
|
|
JP2004131432A
(ja)
|
2002-10-11 |
2004-04-30 |
Kumamoto Technology & Industry Foundation |
悪性腫瘍抑制剤
|
|
WO2004098524A2
(en)
|
2003-05-02 |
2004-11-18 |
Aronex Pharmaceuticals, Inc. |
Lipid platinum complexes and methods of use thereof
|
|
AU2004257375A1
(en)
|
2003-07-21 |
2005-01-27 |
Vasogen Ireland Limited |
Liposomes containing phosphate glycerol groups for treating acute inflammatory condition
|
|
JP2005179313A
(ja)
*
|
2003-12-24 |
2005-07-07 |
Shu Uemura:Kk |
皮膚化粧料用基剤の製造方法および皮膚化粧料
|
|
US7476432B2
(en)
|
2004-05-28 |
2009-01-13 |
Tecton Products |
Phosphorescent pultrusion
|
|
JP2008519784A
(ja)
|
2004-11-12 |
2008-06-12 |
イデア アクチェンゲゼルシャフト |
皮膚状態の治療における拡張表面凝集体
|
|
WO2006086992A2
(en)
|
2005-02-18 |
2006-08-24 |
Liplasome Pharma A/S |
Drug delivery systems containing phqspholipase a2 degradable lipid prodrug derivatives and the therapeutic uses thereof as. e.g. wound healing agents and peroxisome proliferator activated receptor ligands
|
|
US20070042008A1
(en)
|
2005-08-18 |
2007-02-22 |
Bodybio, Inc. |
Compositions containing phosphatidylcholine and essential fatty acids
|
|
EP1933856A4
(en)
|
2005-08-29 |
2008-11-19 |
Sepsicure L L C |
METHOD OF TREATING OR PREVENTING CONDITIONS INDUCED BY GRAM POSITIVE BACTERIA
|
|
CA2634139C
(en)
|
2005-12-20 |
2015-06-23 |
Cenestra, Llc. |
Omega 3 fatty acid formulations
|
|
JP5009547B2
(ja)
*
|
2006-03-31 |
2012-08-22 |
株式会社コーセー |
顔料とリポソームを含む化粧料
|
|
US7544375B1
(en)
|
2006-06-12 |
2009-06-09 |
Swiss Skin Repair, Inc. |
Composition
|
|
ES2599630T3
(es)
|
2006-09-28 |
2017-02-02 |
Hadasit Medical Research Services & Development Limited |
Uso de glicerofosfolípidos para lubricación de las articulaciones
|
|
JP4732307B2
(ja)
*
|
2006-11-20 |
2011-07-27 |
株式会社アンズコーポレーション |
ナノエマルション及びそれを配合した化粧料
|
|
US20100130611A1
(en)
|
2006-12-20 |
2010-05-27 |
Cenestra Llc |
Omega 3 fatty acid formulations
|
|
EP1938801A1
(en)
|
2006-12-22 |
2008-07-02 |
Biofrontera Bioscience GmbH |
Nanoemulsion
|
|
US9511016B2
(en)
|
2007-06-12 |
2016-12-06 |
Epicentrx, Inc. |
Topical composition for treating pain
|
|
ITVR20080006A1
(it)
|
2008-01-23 |
2009-07-24 |
David Ceretta |
Apparato per la realizzazione di elementi d'impasto
|
|
ES2335636B1
(es)
|
2008-02-29 |
2011-05-11 |
Lipotec, S.A. |
Composicion cosmetica o dermofarmaceutica de micelas mixtas.
|
|
JP2009256331A
(ja)
|
2008-03-25 |
2009-11-05 |
Nagase Chemtex Corp |
高尿酸血症、又は痛風の予防、改善、又は治療剤
|
|
US20100105139A1
(en)
|
2008-10-27 |
2010-04-29 |
Remco Alexander Spanjaard |
Ligand Targeted Nanocapsules for the delivery of RNAi and other Agents
|
|
MX2011008204A
(es)
|
2009-02-05 |
2011-12-06 |
Targeted Delivery Technologies Ltd |
Metodos para reducir la proliferacion y viabilidad de los agentes microbianos.
|
|
MX349417B
(es)
|
2009-06-03 |
2017-07-28 |
Charles Mayo John |
Formulaciones para el tratamiento de dolor de tejido profundo.
|
|
BR112012003834A2
(pt)
|
2009-08-21 |
2017-08-08 |
Targeted Delivery Tech Limited |
métodos para tratamento de distúrbios e para tratamentos de deficiências em ácidos graxos, hipertrigliceridemia ou hipercolesterolemia e pacote
|
|
EP2382994A1
(en)
|
2010-04-26 |
2011-11-02 |
Maurizio Victor Cattaneo |
Ligand targeted nanocapsules for the delivery of RNAi and other agents
|
|
WO2011162802A1
(en)
|
2010-06-21 |
2011-12-29 |
Virun, Inc. |
Compositions containing non-polar compounds
|
|
US20120045405A1
(en)
|
2010-08-18 |
2012-02-23 |
Gilman Miles E |
Under eye cream
|
|
GB201206486D0
(en)
|
2012-04-12 |
2012-05-30 |
Sequessome Technology Holdings Ltd |
Vesicular formulations and uses thereof
|
|
GB201208384D0
(en)
|
2012-05-14 |
2012-06-27 |
Sequessome Technology Holdings Ltd |
Vesicular formulations, uses and methods
|
|
GB201208409D0
(en)
|
2012-05-14 |
2012-06-27 |
Sequessome Technology Holdings Ltd |
Vesicular formulations, kits and uses
|
|
CN114949237A
(zh)
|
2013-07-31 |
2022-08-30 |
斯昆申技术控股有限责任公司 |
囊泡
|